Skip to main content
. 2019 Nov 16;2019:9605980. doi: 10.1155/2019/9605980

Figure 2.

Figure 2

Nerolidol protects against LPS-induced alveolar-capillary barrier disruption and leukocyte infiltration. (a) Alveolar-capillary barrier disruption was determined by protein leakage via a Bradford protein assay. (b) Leukocyte infiltration was determined by MPO activity in BALF. Values are expressed as mean ± S.D. of 3-4 mice per group. #P < 0.05 represents a significant difference between the indicated group and the control group; P < 0.05 represents a significant difference between the indicated group and the LPS groups.